Hawk Ridge Capital Management LP Sells 1,543,064 Shares of Acadia Healthcare Company, Inc. $ACHC

Hawk Ridge Capital Management LP decreased its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 64.9% during the 1st quarter, Holdings Channel.com reports. The firm owned 836,033 shares of the company’s stock after selling 1,543,064 shares during the period. Hawk Ridge Capital Management LP’s holdings in Acadia Healthcare were worth $19,555,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also bought and sold shares of the company. Maverick Capital Ltd. raised its stake in shares of Acadia Healthcare by 45.1% in the first quarter. Maverick Capital Ltd. now owns 1,314,116 shares of the company’s stock valued at $30,737,000 after buying an additional 408,697 shares during the period. Quantinno Capital Management LP increased its holdings in Acadia Healthcare by 25.5% in the 1st quarter. Quantinno Capital Management LP now owns 117,676 shares of the company’s stock worth $2,752,000 after acquiring an additional 23,913 shares during the last quarter. Clough Capital Partners L P purchased a new stake in Acadia Healthcare in the 1st quarter worth about $5,359,000. Waverly Advisors LLC purchased a new stake in Acadia Healthcare during the first quarter valued at about $344,000. Finally, Atika Capital Management LLC bought a new position in Acadia Healthcare during the first quarter worth about $2,868,000.

Acadia Healthcare Stock Performance

Acadia Healthcare stock opened at $32.50 on Tuesday. Acadia Healthcare Company, Inc. has a 1-year low of $11.43 and a 1-year high of $35.83. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27. The firm has a market capitalization of $2.99 billion, a PE ratio of -2.66, a price-to-earnings-growth ratio of 11.51 and a beta of 0.64. The firm’s 50 day simple moving average is $27.78 and its 200 day simple moving average is $23.36.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.28 by $0.09. The firm had revenue of $828.80 million during the quarter, compared to the consensus estimate of $823.51 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The business’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same period last year, the firm earned $0.40 EPS. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. As a group, analysts expect that Acadia Healthcare Company, Inc. will post 1.5 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the stock. Guggenheim boosted their price target on shares of Acadia Healthcare from $26.00 to $31.00 and gave the company a “buy” rating in a research report on Monday, May 4th. UBS Group boosted their target price on shares of Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a report on Thursday, July 9th. Royal Bank Of Canada increased their target price on Acadia Healthcare from $28.00 to $31.00 and gave the stock an “outperform” rating in a research report on Monday, May 4th. Weiss Ratings reiterated a “sell (d)” rating on shares of Acadia Healthcare in a research report on Friday, June 12th. Finally, Cantor Fitzgerald boosted their price objective on Acadia Healthcare from $20.00 to $30.00 and gave the company a “neutral” rating in a research note on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $28.69.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.